Literature DB >> 26811521

Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer.

Scott D Ramsey1, Aasthaa Bansal2, Catherine R Fedorenko2, David K Blough2, Karen A Overstreet2, Veena Shankaran2, Polly Newcomb2.   

Abstract

PURPOSE: Patients with cancer are more likely to file for bankruptcy than the general population, but the impact of severe financial distress on health outcomes among patients with cancer is not known.
METHODS: We linked Western Washington SEER Cancer Registry records with federal bankruptcy records for the region. By using propensity score matching to account for differences in several demographic and clinical factors between patients who did and did not file for bankruptcy, we then fit Cox proportional hazards models to examine the relationship between bankruptcy filing and survival.
RESULTS: Between 1995 and 2009, 231,596 persons were diagnosed with cancer. Patients who filed for bankruptcy (n = 4,728) were more likely to be younger, female, and nonwhite, to have local- or regional- (v distant-) stage disease at diagnosis, and have received treatment. After propensity score matching, 3,841 patients remained in each group (bankruptcy v no bankruptcy). In the matched sample, mean age was 53.0 years, 54% were men, mean income was $49,000, and majorities were white (86%), married (60%), and urban (91%) and had local- or regional-stage disease at diagnosis (84%). Both groups received similar initial treatments. The adjusted hazard ratio for mortality among patients with cancer who filed for bankruptcy versus those who did not was 1.79 (95% CI, 1.64 to 1.96). Hazard ratios varied by cancer type: colorectal, prostate, and thyroid cancers had the highest hazard ratios. Excluding patients with distant-stage disease from the models did not have an effect on results.
CONCLUSION: Severe financial distress requiring bankruptcy protection after cancer diagnosis appears to be a risk factor for mortality. Further research is needed to understand the process by which extreme financial distress influences survival after cancer diagnosis and to find strategies that could mitigate this risk.
© 2016 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2016        PMID: 26811521      PMCID: PMC4933128          DOI: 10.1200/JCO.2015.64.6620

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  18 in total

1.  Full disclosure--out-of-pocket costs as side effects.

Authors:  Peter A Ubel; Amy P Abernethy; S Yousuf Zafar
Journal:  N Engl J Med       Date:  2013-10-17       Impact factor: 91.245

2.  The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer.

Authors:  Dawn L Hershman; Jennifer Tsui; Jay Meyer; Sherry Glied; Grace Clarke Hillyer; Jason D Wright; Alfred I Neugut
Journal:  J Natl Cancer Inst       Date:  2014-10-27       Impact factor: 13.506

3.  Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis.

Authors:  Veena Shankaran; Sanjay Jolly; David Blough; Scott D Ramsey
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

4.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.

Authors:  S Yousuf Zafar; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy M Goetzinger; Xiaoyin Zhong; Amy P Abernethy
Journal:  Oncologist       Date:  2013-02-26

5.  Out-of-pocket costs and oral cancer medication discontinuation in the elderly.

Authors:  Nantana Kaisaeng; Spencer E Harpe; Norman V Carroll
Journal:  J Manag Care Spec Pharm       Date:  2014-07

6.  Financial hardship and mortality among older adults using the 1996-2004 Health and Retirement Study.

Authors:  Reginald D Tucker-Seeley; Yi Li; S V Subramanian; Glorian Sorensen
Journal:  Ann Epidemiol       Date:  2009-12       Impact factor: 3.797

7.  Financial strain predicts recurrent events among women with coronary artery disease.

Authors:  Anastasia Georgiades; Imre Janszky; May Blom; Krisztina D László; Staffan Ahnve
Journal:  Int J Cardiol       Date:  2008-07-11       Impact factor: 4.164

Review 8.  Cancer disparities by race/ethnicity and socioeconomic status.

Authors:  Elizabeth Ward; Ahmedin Jemal; Vilma Cokkinides; Gopal K Singh; Cheryll Cardinez; Asma Ghafoor; Michael Thun
Journal:  CA Cancer J Clin       Date:  2004 Mar-Apr       Impact factor: 508.702

9.  Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study.

Authors:  Annika Rosengren; Steven Hawken; Stephanie Ounpuu; Karen Sliwa; Mohammad Zubaid; Wael A Almahmeed; Kathleen Ngu Blackett; Chitr Sitthi-amorn; Hiroshi Sato; Salim Yusuf
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

10.  Self-reported economic difficulties and coronary events in men: evidence from the Whitehall II study.

Authors:  J E Ferrie; P Martikainen; M J Shipley; M G Marmot
Journal:  Int J Epidemiol       Date:  2005-04-14       Impact factor: 7.196

View more
  198 in total

1.  Characteristics of Emergency Department Visits and Select Predictors of Hospitalization for Adults With Newly Diagnosed Cancer in a Safety-Net Health System.

Authors:  Arthur S Hong; Navid Sadeghi; Valorie Harvey; Simon Craddock Lee; Ethan A Halm
Journal:  J Oncol Pract       Date:  2019-04-09       Impact factor: 3.840

2.  Improving quality of life among latino cancer survivors: Design of a randomized trial of patient navigation.

Authors:  Amelie G Ramirez; Kipling J Gallion; Arely Perez; Edgar Munoz; Dorothy Long Parma; Patricia I Moreno; Frank J Penedo
Journal:  Contemp Clin Trials       Date:  2018-11-03       Impact factor: 2.226

Review 3.  Medical-Financial Partnerships: Cross-Sector Collaborations Between Medical and Financial Services to Improve Health.

Authors:  Orly N Bell; Michael K Hole; Karl Johnson; Lucy E Marcil; Barry S Solomon; Adam Schickedanz
Journal:  Acad Pediatr       Date:  2019-10-13       Impact factor: 3.107

4.  Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.

Authors:  Christine Leopold; Anita K Wagner; Fang Zhang; Christine Y Lu; Craig C Earle; Larissa Nekhlyudov; Dennis Ross-Degnan; J Frank Wharam
Journal:  Breast Cancer Res Treat       Date:  2018-06-01       Impact factor: 4.872

5.  With Colorectal Cancer Treatment, Physical Toxicity Is Not the Only Concern.

Authors:  Andrea Phillips Sitlinger; S Yousuf Zafar
Journal:  Dis Colon Rectum       Date:  2018-01       Impact factor: 4.585

6.  Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine.

Authors:  Tania Jaber; Steven G Waguespack; Maria E Cabanillas; Mohamed Elbanan; Thinh Vu; Ramona Dadu; Steven I Sherman; Moran Amit; Elmer B Santos; Mark Zafereo; Naifa L Busaidy
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

Review 7.  Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.

Authors:  Hamzeh Albaba; Charles Lim; Natasha B Leighl
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

8.  Financial toxicity in gynecologic oncology.

Authors:  Sara Bouberhan; Meghan Shea; Alice Kennedy; Adrienne Erlinger; Hannah Stack-Dunnbier; Mary K Buss; Laureen Moss; Kathleen Nolan; Christopher Awtrey; John L Dalrymple; Leslie Garrett; Fong W Liu; Michele R Hacker; Katharine M Esselen
Journal:  Gynecol Oncol       Date:  2019-04-30       Impact factor: 5.482

Review 9.  Influences of the Results from STRIVE Trial on the Combination Androgen Depletion Therapy for Advanced Prostate Cancer.

Authors:  Hideyuki Akaza
Journal:  Curr Urol Rep       Date:  2016-11       Impact factor: 3.092

10.  Alternative payment and care-delivery models in oncology: A systematic review.

Authors:  Emeline M Aviki; Stephen M Schleicher; Samyukta Mullangi; Konstantina Matsoukas; Deborah Korenstein
Journal:  Cancer       Date:  2018-04-06       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.